Cadila Healthcare receives approval from USFDA for Zolmitriptan tablets
Cadila Healthcare has received final approval for Zolmitriptan tablets USP, from the USFDA. The company has received final approval to market Zolmitriptan Tablets, 2.5 mg and 5 mg,...